A study to see whether a new medicated calamine lotion reduces itching and skin discomfort in children with dermatitis

Development and validation of calamine lotion infused with vitamin C, vitamin E and chlorpheniramine - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100064

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L30- Other and unspecified dermatitis

Interventions

Intervention1: Topical application of calamine lotion infused with vitamin C, vitamin E and chlorpheniramine, applied as per protocol.: calamine lotion is applied in children with dermatitis for a per

Eligibility

Inclusion criteria

Inclusion criteria: Children aged 2-12 years diagnosed clinically with dermatitis like allergic dermatitis, psoriasis or lichen planus whose caregivers provide written informed consent.

Exclusion criteria

Exclusion criteria: Children with infected skin lesions, known hypersensitivity to study components, severe systemic illness, or those on concurrent systemic immunosuppressive therapy.

Design outcomes

Primary

Measure	Time frame
Reduction in pruritus severity assessed using a validated itch score at the end of 4 weeks.Timepoint: Reduction in pruritus severity assessed using a validated itch score at the end of 4 weeks.	—

Secondary

Measure	Time frame
Improvement in sleep quality Caregiver satisfaction Treatment adherence Safety and tolerability of the formulationTimepoint: baseline, 2 weeks, 4 weeks	—

Countries

India

Contacts

Public ContactDr Navin

Saveetha medical college hospital

navinu.smc@saveetha.com9487002379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026